Gui-Xue Wang
Overview
Explore the profile of Gui-Xue Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
378
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Teng F, Wang W, Wang Z, Wang G
Biofabrication
. 2024 Feb;
16(2).
PMID: 38350130
This study endeavors to investigate the progression, research focal points, and budding trends in the realm of skin bioprinting over the past decade from a structural and temporal dynamics standpoint....
2.
Jiang M, Zhao X, Jiang Z, Wang G, Zhang D
Clin Chim Acta
. 2022 Feb;
529:34-41.
PMID: 35149004
Accumulation of reactive oxygen species (ROS) can induce both protein tyrosine nitration and endothelial dysfunction in atherosclerosis. Endothelial dysfunction refers to impaired endothelium-dependent vasorelaxation that can be triggered by an...
3.
Huang Y, Tang S, Xu X, Zeng Y, He X, Li Y, et al.
Front Pharmacol
. 2020 Aug;
11:1071.
PMID: 32765274
Background: Currently, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread globally, causing an unprecedented pandemic. However, there is no specific antiviral therapy for coronavirus disease 2019 (COVID-19). We conducted...
4.
Zhong Y, Wang Y, Luo L, Nurhidayah D, Maruf A, Gregersen H, et al.
Nanotechnology
. 2018 Dec;
30(14):145601.
PMID: 30524021
The development of the tumor-targeting ability of nanocarriers is of paramount importance for gene delivery into tumor lesions as well as to avoid biotoxicity. Here we report the synthesis of...
5.
Luo L, Wu W, Sun D, Dai H, Wang Y, Zhong Y, et al.
Bioconjug Chem
. 2018 Aug;
29(9):2936-2944.
PMID: 30148623
Melittin (MLT), as a natural active biomolecule, can penetrate the tumor cell membrane to play a role in cancer treatment and will attract more attention in future development of antitumor...
6.
Wu W, Luo L, Wang Y, Wu Q, Dai H, Li J, et al.
Theranostics
. 2018 Jun;
8(11):3038-3058.
PMID: 29896301
Nanotechnology-based antitumor drug delivery systems, known as nanocarriers, have demonstrated their efficacy in recent years. Typically, the size of the nanocarriers is around 100 nm. It is imperative to achieve...
7.
Zhang P, Guo J, Yan P, Chen Y, Wang W, Dai Y, et al.
Appl Environ Microbiol
. 2018 Mar;
84(9).
PMID: 29500260
Pollutant degradation is present mainly in the surface layer of biofilms, and the surface layer is the most vulnerable to impairment by toxic pollutants. In this work, the effects of...
8.
Ariyanti A, Sisjayawan J, Zhang J, Zhang J, Wang G, Miyagishi M, et al.
Oncotarget
. 2017 Dec;
8(57):97187-97205.
PMID: 29228603
Hind-limb ischemia (HLI) is one of the major complication of diabetic patients. Angiogenesis potential in diabetic patients is severely disrupted, and the mechanism underlying it has not been fully elucidated,...
9.
Chen J, Wu Q, Luo L, Wang Y, Zhong Y, Dai H, et al.
Int J Nanomedicine
. 2017 Aug;
12:5745-5760.
PMID: 28848351
Further specific target-ability development of biodegradable nanocarriers is extremely important to promote their security and efficiency in antitumor drug-delivery applications. In this study, a facilely prepared poly(lactic--glycolic acid) (PLGA)-polyethylene glycol...
10.
Zhao X, Wu Q, Peng J, Pan L, Ren Z, Liu H, et al.
Mol Med Rep
. 2016 Dec;
15(2):712-718.
PMID: 28000893
Hyperlipidemia is a risk factor for Alzheimer's disease (AD) and other neurodegenerative diseases. Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a lipid regulatory gene involved in cell apoptosis. However, the...